tiprankstipranks
Trending News
More News >
Petros Pharmaceuticals (PTPI)
OTHER OTC:PTPI
US Market
Advertisement

Petros Pharmaceuticals (PTPI) Ownership - Who Owns Petros Pharmaceuticals?

Compare
197 Followers

Petros Pharmaceuticals (PTPI) Ownership Overview

100.00%
100.00% Public Companies and
Individual Investors
The ownership structure of Petros Pharmaceuticals (PTPI) stock is a mix of institutional, retail, and individual investors. , and 100.00% is owned by Public Companies and Individual Investors.
The ownership structure of Petros Pharmaceuticals (PTPI) stock is a mix of institutional, retail, and individual investors. , 100.00% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
35,806Institution0.11%1,003
31,811Institution0.10%4,231

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
35,806Institution0.11%1,003

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Petros Pharmaceuticals (PTPI)?
Currently, no data Available
What percentage of Petros Pharmaceuticals (PTPI) stock is held by institutional investors?
Currently, no data Available
What percentage of Petros Pharmaceuticals (PTPI) stock is held by retail investors?
According to the latest TipRanks data, approximately 100.00% of Petros Pharmaceuticals (PTPI) stock is held by retail investors.
    Who owns the most shares of Petros Pharmaceuticals (PTPI)?
    Fidelity Concord Street Trust owns the most shares of Petros Pharmaceuticals (PTPI).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis